துறை ஆஃப் ஹெபடோபிலியரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from துறை ஆஃப் ஹெபடோபிலியரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In துறை ஆஃப் ஹெபடோபிலியரி Today - Breaking & Trending Today

Super Specialised Hospital: Project staring at long delays

The government will again extend the period of a project taken to set up a modern healthcare facility at the capital Bangabandhu Sheikh Mujib Medical University (BSMMU) after the project authorities failed to complete the work on schedule mainly due to the pandemic. The project authorities are now seeking an extension of one and a half years and an additional Tk 195 crore for ....

South Korea , South Korean , Zulfiqur Rahman Khan , Sheikh Hasina , Economic Development Cooperation Fund , Bangabandhu Sheikh Mujib Medical University , Department Of Hepatobiliary , Committee Of National Economic Council Ecnec , Executive Committee , National Economic Council , Prime Minister Sheikh Hasina , Super Specialised Hospital , Liver Transplantation Surgery , தெற்கு கொரியா , தெற்கு கொரியன் , ஷேக் ஹசினா , பொருளாதார வளர்ச்சி ஒத்துழைப்பு நிதி , பங்கபந்து ஷேக் முஜிப் மருத்துவ பல்கலைக்கழகம் , துறை ஆஃப் ஹெபடோபிலியரி , நிர்வாகி குழு , தேசிய பொருளாதார சபை , ப்ரைம் அமைச்சர் ஷேக் ஹசினா , அருமை சிறப்பு மருத்துவமனை , கல்லீரல் மாற்று அறுவை சிகிச்சை அறுவை சிகிச்சை ,

Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan


Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan
Font : A-A+
from Treatment with Lynparza
More Than 20,000 Patients in Japan Now Qualify for Genetic Testing
SALT LAKE CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) In an announcement that will help more people with advanced prostate and pancreatic cancers in Japan, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will receive reimbursement for its BRACAnalysis
® Diagnostic System, which helps physicians determine whether certain patients will qualify and potentially benefit from treatment with the PARP inhibitor, Lynparza (olaparib). BRACAnalysis was approved by Japan’s Ministry of Health, Labour and Welfare (MHLW) in October 2020 as a companion diagnostic for these indications and the reimbursement decision is now in effect. ....

United States , Hideki Ueno , Jared Maxwell , Bracanalysis Cdx , Scott Gleason , Nicole Lambert , Hiroji Uemura , Hu Group Holdings Inc , Tsrl Inc , Bank Intl , Merck Co Inc , Yokohama City University Medical Center , International Agency For Research On Cancer , Japan Ministry Of Health , National Cancer Center Hospital , World Health Organization , Department Of Hepatobiliary , Prometheus Labs Inc , Genetics Inc , Exchange Commission , Supreme Court , World Cancer Research Fund , Department Of Urology , Alice Corp , Pancreatic Cancer , Japan Now Qualify ,